WO2010003078A3 - Processus de granulation par fusion - Google Patents
Processus de granulation par fusion Download PDFInfo
- Publication number
- WO2010003078A3 WO2010003078A3 PCT/US2009/049548 US2009049548W WO2010003078A3 WO 2010003078 A3 WO2010003078 A3 WO 2010003078A3 US 2009049548 W US2009049548 W US 2009049548W WO 2010003078 A3 WO2010003078 A3 WO 2010003078A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- granulation process
- melt granulation
- quinoline compound
- extruder
- contain
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1682—Processes
- A61K9/1694—Processes resulting in granules or microspheres of the matrix type containing more than 5% of excipient
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4709—Non-condensed quinolines and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1629—Organic macromolecular compounds
- A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2072—Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
- A61K9/2077—Tablets comprising drug-containing microparticles in a substantial amount of supporting matrix; Multiparticulate tablets
Landscapes
- Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Engineering & Computer Science (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Priority Applications (11)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
MX2010014566A MX2010014566A (es) | 2008-07-03 | 2009-07-02 | Proceso de granulacion de fundido. |
RU2011103651/15A RU2491918C2 (ru) | 2008-07-03 | 2009-07-02 | Способ грануляции из расплава |
BRPI0913843A BRPI0913843A2 (pt) | 2008-07-03 | 2009-07-02 | processo de granulação por fusão |
EP09774527A EP2309987B1 (fr) | 2008-07-03 | 2009-07-02 | Processus de granulation par fusion |
PL09774527T PL2309987T3 (pl) | 2008-07-03 | 2009-07-02 | Granulacja metodą stapiania |
CA2729596A CA2729596A1 (fr) | 2008-07-03 | 2009-07-02 | Processus de granulation par fusion |
ES09774527T ES2393949T3 (es) | 2008-07-03 | 2009-07-02 | Proceso de granulación en estado fundido |
US13/000,044 US20110092515A1 (en) | 2008-07-03 | 2009-07-02 | Melt granulation process |
AU2009266833A AU2009266833B2 (en) | 2008-07-03 | 2009-07-02 | Melt granulation process |
JP2011516879A JP2011526928A (ja) | 2008-07-03 | 2009-07-02 | 溶融造粒方法 |
CN200980125276XA CN102076329B (zh) | 2008-07-03 | 2009-07-02 | 熔融制粒法 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US13385108P | 2008-07-03 | 2008-07-03 | |
US61/133,851 | 2008-07-03 |
Publications (2)
Publication Number | Publication Date |
---|---|
WO2010003078A2 WO2010003078A2 (fr) | 2010-01-07 |
WO2010003078A3 true WO2010003078A3 (fr) | 2010-05-27 |
Family
ID=41328880
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/US2009/049548 WO2010003078A2 (fr) | 2008-07-03 | 2009-07-02 | Processus de granulation par fusion |
Country Status (14)
Country | Link |
---|---|
US (1) | US20110092515A1 (fr) |
EP (1) | EP2309987B1 (fr) |
JP (1) | JP2011526928A (fr) |
KR (1) | KR20110031485A (fr) |
CN (1) | CN102076329B (fr) |
AU (1) | AU2009266833B2 (fr) |
BR (1) | BRPI0913843A2 (fr) |
CA (1) | CA2729596A1 (fr) |
ES (1) | ES2393949T3 (fr) |
MX (1) | MX2010014566A (fr) |
PL (1) | PL2309987T3 (fr) |
PT (1) | PT2309987E (fr) |
RU (1) | RU2491918C2 (fr) |
WO (1) | WO2010003078A2 (fr) |
Families Citing this family (35)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7776314B2 (en) | 2002-06-17 | 2010-08-17 | Grunenthal Gmbh | Abuse-proofed dosage system |
DE102005005446A1 (de) | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Bruchfeste Darreichungsformen mit retardierter Freisetzung |
US20070048228A1 (en) | 2003-08-06 | 2007-03-01 | Elisabeth Arkenau-Maric | Abuse-proofed dosage form |
DE10336400A1 (de) | 2003-08-06 | 2005-03-24 | Grünenthal GmbH | Gegen Missbrauch gesicherte Darreichungsform |
DE10361596A1 (de) | 2003-12-24 | 2005-09-29 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform |
DE102004032049A1 (de) | 2004-07-01 | 2006-01-19 | Grünenthal GmbH | Gegen Missbrauch gesicherte, orale Darreichungsform |
DE102005005449A1 (de) | 2005-02-04 | 2006-08-10 | Grünenthal GmbH | Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform |
KR101616246B1 (ko) | 2008-01-25 | 2016-05-02 | 그뤼넨탈 게엠베하 | 약제학적 투여형 |
PL2273983T3 (pl) | 2008-05-09 | 2017-01-31 | Grünenthal GmbH | Sposób wytwarzania pośredniego preparatu proszkowego i końcowej stałej postaci dawkowania z zastosowaniem etapu zestalania rozpyłowego |
WO2011009604A1 (fr) | 2009-07-22 | 2011-01-27 | Grünenthal GmbH | Forme galénique inviolable stabilisée à loxydation |
JP5667183B2 (ja) | 2009-07-22 | 2015-02-12 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | 加熱溶融押出成型した制御放出性投与剤型 |
EP2531176B1 (fr) * | 2010-02-03 | 2016-09-07 | Grünenthal GmbH | Préparation de composition pharmaceutique en poudre au moyen d'une extrudeuse |
BR112013005194A2 (pt) | 2010-09-02 | 2016-05-03 | Gruenenthal Gmbh | forma de dosagem resistente à violação compreendendo sal inorgânico |
ES2487244T3 (es) | 2010-09-02 | 2014-08-20 | Grünenthal GmbH | Forma de dosificación resistente a la manipulación que comprende un polímero aniónico |
MX348491B (es) | 2011-07-29 | 2017-06-15 | Gruenenthal Gmbh | Tableta a prueba de manipulacion que proporciona liberacion inmediata de fármaco. |
MX348054B (es) | 2011-07-29 | 2017-05-25 | Gruenenthal Gmbh | Tableta a prueba de alteracion que proporciona liberacion inmediata del farmaco. |
BR112014019988A8 (pt) | 2012-02-28 | 2017-07-11 | Gruenenthal Gmbh | Forma de dosagem resistente a socamento compreendendo um composto farmacologicamente ativo e um polímero aniônico |
TR201815502T4 (tr) | 2012-04-18 | 2018-11-21 | Gruenenthal Gmbh | Kurcalama veya dirençli ve doz boşalımına dirençli farmasötik dozaj formu. |
US10064945B2 (en) | 2012-05-11 | 2018-09-04 | Gruenenthal Gmbh | Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc |
GB2502080A (en) * | 2012-05-15 | 2013-11-20 | Univ Bradford | Preparation of metastable polymorphs of active pharmaceutical ingredients |
US9395468B2 (en) | 2012-08-27 | 2016-07-19 | Ocular Dynamics, Llc | Contact lens with a hydrophilic layer |
HUE048041T2 (hu) | 2013-05-27 | 2020-05-28 | Steerlife India Private Ltd | Forró olvadék-fragmentációs extruder és eljárás |
US10154966B2 (en) | 2013-05-29 | 2018-12-18 | Grünenthal GmbH | Tamper-resistant dosage form containing one or more particles |
JP6466417B2 (ja) | 2013-05-29 | 2019-02-06 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | 二峰性放出プロファイルを有する改変防止(tamper−resistant)剤形 |
EA032465B1 (ru) | 2013-07-12 | 2019-05-31 | Грюненталь Гмбх | Защищенная от применения не по назначению пероральная фармацевтическая лекарственная форма, содержащая этиленвинилацетатный полимер, и способ ее изготовления |
EP3988992A1 (fr) | 2013-11-15 | 2022-04-27 | Tangible Science, Inc. | Lentille de contact avec couche hydrophile |
WO2015078891A1 (fr) | 2013-11-26 | 2015-06-04 | Farmaceutici Formenti S.P.A. | Préparation de composition pharmaceutique en poudre par cryo-broyage |
CA2947786A1 (fr) | 2014-05-12 | 2015-11-19 | Grunenthal Gmbh | Formulation pour capsule a liberation immediate resistant aux manipulations illicites comprenant du tapentadol |
CA2949422A1 (fr) | 2014-05-26 | 2015-12-03 | Grunenthal Gmbh | Microparticules protegees contre une liberation massive dans l'ethanol |
WO2016094533A1 (fr) | 2014-12-09 | 2016-06-16 | Ocular Dynamics, Llc | Revêtement de dispositif médical avec une couche biocompatible |
JP2018517676A (ja) | 2015-04-24 | 2018-07-05 | グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング | 即時放出および溶媒抽出に対する耐性を有する改変防止製剤 |
EP3346991A1 (fr) | 2015-09-10 | 2018-07-18 | Grünenthal GmbH | Protection contre un surdosage par voie orale à l'aide de formulations à libération immédiate dissuasives d'abus |
US10342886B2 (en) | 2016-01-26 | 2019-07-09 | S.C. Johnson & Son, Inc. | Extruded wax melt and method of producing same |
US10010638B2 (en) | 2016-06-14 | 2018-07-03 | S. C. Johnson & Son, Inc. | Wax melt with filler |
KR102530612B1 (ko) * | 2020-08-21 | 2023-05-09 | 한국휴텍스제약 주식회사 | 자가과립화 기법을 이용한 딜티아젬 서방정 조성물의 제조방법 |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20010036476A1 (en) * | 1994-11-04 | 2001-11-01 | Euro-Celtique S.A. | Melt-extruded orally administrable opioid formulations |
WO2007064719A2 (fr) * | 2005-11-29 | 2007-06-07 | Novartis Ag | Formulations de quinolinones |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE19504832A1 (de) * | 1995-02-14 | 1996-08-22 | Basf Ag | Feste Wirkstoff-Zubereitungen |
HN1998000115A (es) * | 1997-08-21 | 1999-06-02 | Warner Lambert Co | Formas de dosificación farmacéuticas sólidas |
CN1960731B (zh) * | 2004-02-20 | 2011-12-07 | 诺华疫苗和诊断公司 | 调节炎性和转移过程的方法 |
WO2006122021A1 (fr) * | 2005-05-10 | 2006-11-16 | Novartis Ag | Procede d'extrusion permettant de fabriquer des compositions renfermant des composes therapeutiques peu compressibles |
CN101166517B (zh) * | 2005-05-10 | 2012-01-04 | 诺瓦提斯公司 | 制备含有可压性差的治疗性化合物的组合物的挤压方法 |
MX2007014782A (es) * | 2005-05-23 | 2008-02-19 | Novartis Ag | Formas cristalinas y otras formas de las sales de acido lactico de 4-amino-5-fluoro-3-[6-(4-metilpiperazin-1-il)-1h-bencimidazol-2 -il]-1h quinolin-2-ona. |
CN101316593B (zh) * | 2005-11-29 | 2012-05-02 | 诺瓦提斯公司 | 喹啉酮类的制剂 |
-
2009
- 2009-07-02 BR BRPI0913843A patent/BRPI0913843A2/pt not_active IP Right Cessation
- 2009-07-02 US US13/000,044 patent/US20110092515A1/en not_active Abandoned
- 2009-07-02 CA CA2729596A patent/CA2729596A1/fr not_active Abandoned
- 2009-07-02 RU RU2011103651/15A patent/RU2491918C2/ru not_active IP Right Cessation
- 2009-07-02 MX MX2010014566A patent/MX2010014566A/es active IP Right Grant
- 2009-07-02 AU AU2009266833A patent/AU2009266833B2/en not_active Ceased
- 2009-07-02 JP JP2011516879A patent/JP2011526928A/ja active Pending
- 2009-07-02 PT PT97745277T patent/PT2309987E/pt unknown
- 2009-07-02 EP EP09774527A patent/EP2309987B1/fr not_active Not-in-force
- 2009-07-02 CN CN200980125276XA patent/CN102076329B/zh not_active Expired - Fee Related
- 2009-07-02 ES ES09774527T patent/ES2393949T3/es active Active
- 2009-07-02 WO PCT/US2009/049548 patent/WO2010003078A2/fr active Application Filing
- 2009-07-02 PL PL09774527T patent/PL2309987T3/pl unknown
- 2009-07-02 KR KR1020117002593A patent/KR20110031485A/ko not_active Application Discontinuation
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20010036476A1 (en) * | 1994-11-04 | 2001-11-01 | Euro-Celtique S.A. | Melt-extruded orally administrable opioid formulations |
WO2007064719A2 (fr) * | 2005-11-29 | 2007-06-07 | Novartis Ag | Formulations de quinolinones |
Also Published As
Publication number | Publication date |
---|---|
CN102076329B (zh) | 2013-03-06 |
WO2010003078A2 (fr) | 2010-01-07 |
ES2393949T3 (es) | 2013-01-02 |
AU2009266833A1 (en) | 2010-01-07 |
CA2729596A1 (fr) | 2010-01-07 |
US20110092515A1 (en) | 2011-04-21 |
BRPI0913843A2 (pt) | 2015-10-20 |
RU2011103651A (ru) | 2012-08-10 |
KR20110031485A (ko) | 2011-03-28 |
JP2011526928A (ja) | 2011-10-20 |
AU2009266833B2 (en) | 2013-01-31 |
PT2309987E (pt) | 2012-12-13 |
RU2491918C2 (ru) | 2013-09-10 |
EP2309987B1 (fr) | 2012-08-29 |
CN102076329A (zh) | 2011-05-25 |
PL2309987T3 (pl) | 2013-01-31 |
EP2309987A2 (fr) | 2011-04-20 |
MX2010014566A (es) | 2011-02-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2010003078A3 (fr) | Processus de granulation par fusion | |
TNSN07415A1 (en) | Extrusion process for making compositions with poorly compressible therapeutic compounds | |
EP2194093B8 (fr) | Composition de résine, composition de résine de moulage préparée à l'aide de celle-ci, stratifiés et procédé de fabrication des stratifiés | |
IL219530A (en) | Converted 4-aminocyclohexane compounds, drugs containing these compounds and their use in the preparation of drugs | |
TN2009000093A1 (en) | Pharmaceutical compositions comprising nilotinib or its salt | |
EP2057002A4 (fr) | Système de moulage et de mélange, entre autres choses | |
WO2012010401A3 (fr) | Mélange plastique | |
EP2388282A4 (fr) | Copolymère de maléimide, procédé de production du copolymère et compositions de résine thermorésistantes contenant ledit copolymère | |
EP2083032A4 (fr) | Composition polymérisable, résine réticulable, procédé de production et d'utilisation | |
WO2010015657A3 (fr) | Nouveaux alcoxypyrazoles | |
PL2300417T3 (pl) | Sposób wytwarzania estrów kwasu 2-(aminometylideno)-4,4-difluoro-3-oksomasłowego | |
WO2012085927A3 (fr) | Compositions de tadalafil | |
EP2206743A4 (fr) | Adjuvant de fabrication pulvérulent pour résines à base de polyoléfine, son procédé de production, composition de résine et article moulé | |
EP2253668A4 (fr) | Agent d'amélioration de la fluidité pour une résine de polycarbonate aromatique, procédé de fabrication de l'agent améliorant la fluidité pour une résine de polycarbonate aromatique, composition de résine de polycarbonate aromatique et produit moulé | |
EP2228405A4 (fr) | Procédé de production d'une composition à base de copolymère d'éthylène et d'alcool vinylique, et procédé de production de pastilles de copolymère d'éthylène et d'alcool vinylique | |
EP2351764A4 (fr) | Composé de tréhalose, son procédé de fabrication et produit pharmaceutique contenant le composé | |
EP2221341A4 (fr) | Composition de résine de polycarbonate, article moulé en résine de polycarbonate et procédé pour la production de l'article moulé en résine de polycarbonate | |
EP2578640A4 (fr) | Mélange de résines et pastilles destinés à être transformés à l'état fondu et procédé de production pour des articles en résine moulés les utilisant | |
EP2573130A4 (fr) | Pastilles de mélange-maître, leur procédé de fabrication et composition de résine de polyamide contenant les pastilles de mélange-maître | |
EP2546271A4 (fr) | Composition réticulable, produit réticulé et son procédé de production, structure multicouche, agent de réticulation et mélange et son procédé de préparation | |
WO2009092702A3 (fr) | Carboxylate de ((2s,4r)-4,6-dihydroxytétrahydro-2h-pyran-2-yl)méthyle et son procédé de fabrication | |
EP2208745A4 (fr) | Composé polymère, son procédé de fabrication et composition contenant le composé polymère | |
ZA201004118B (en) | Process for the production of 1,2-propanediol | |
EP2025663A4 (fr) | Nouveau composé d'acide carboxylique, son application et son procédé de production | |
FR2909671B1 (fr) | Procede de preparation de composes 1,3,2-oxazaborolidines |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 200980125276.X Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 09774527 Country of ref document: EP Kind code of ref document: A2 |
|
DPE1 | Request for preliminary examination filed after expiration of 19th month from priority date (pct application filed from 20040101) | ||
WWE | Wipo information: entry into national phase |
Ref document number: 2009266833 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 13000044 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: MX/A/2010/014566 Country of ref document: MX |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2009774527 Country of ref document: EP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 9189/DELNP/2010 Country of ref document: IN |
|
ENP | Entry into the national phase |
Ref document number: 2011516879 Country of ref document: JP Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 2729596 Country of ref document: CA |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
ENP | Entry into the national phase |
Ref document number: 2009266833 Country of ref document: AU Date of ref document: 20090702 Kind code of ref document: A |
|
ENP | Entry into the national phase |
Ref document number: 20117002593 Country of ref document: KR Kind code of ref document: A |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2011103651 Country of ref document: RU |
|
ENP | Entry into the national phase |
Ref document number: PI0913843 Country of ref document: BR Kind code of ref document: A2 Effective date: 20101231 |